Corpus Intelligence IC Memo — FRIENDS BEHAVIORAL HEALTH SYSTEM 2026-04-26 15:52 UTC
IC Memo — FRIENDS BEHAVIORAL HEALTH SYSTEM
Investment Committee Memorandum | PA | 192 beds | Grade D | EBITDA uplift $3.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

FRIENDS BEHAVIORAL HEALTH SYSTEM

CCN 394008 | PHILADELPHIA, PA | 192 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

FRIENDS BEHAVIORAL HEALTH SYSTEM is a 192-bed suburban community hospital in PHILADELPHIA, PA with $48.0M in net patient revenue and a -0.8% operating margin. The hospital serves a payer mix of 8.4% Medicare, 3.3% Medicaid, and 88.3% commercial.

Thesis: Undervalued. Our ML models identify $3.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -0.8% to 6.6% (+736bps).

Net Revenue HCRIS$48.0M
Current EBITDA COMPUTED$-369K
Operating Margin COMPUTED-0.8%
Occupancy HCRIS88.8%
Revenue / Bed COMPUTED$250K
Net-to-Gross HCRIS38.7%
Distress Probability ML40.9%

2. Market Context & Competitive Position

225
PA Hospitals
-4.4%
State Median Margin
98
Comparable Hospitals

PA has 225 Medicare-certified hospitals with a median operating margin of -4.4%. The target's margin of -0.8% places it above the state median. Among 98 size-comparable peers (96-384 beds), the median margin is -7.6%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (96-384), prioritizing same-state peers. 98 hospitals in the comp set.

HospitalStateBedsRevenueMargin
FRIENDS BEHAVIORAL HEALTH SYST (Target)PA192$48.0M-0.8%
PRESBYTERIAN MEDICAL CENTERPA328$988.5M-18.9%
UPMC MAGEE-WOMENS HOSPITALPA347$910.8M-23.9%
UPMC CHILDRENS HOSPITAL OF PGHPA317$816.7M-2.5%
GEISINGER WYOMING VALLEY MED CPA309$782.7M5.9%
WESTERN PENNSYLVANIA HOSPITALPA255$776.4M11.1%
LANKENAU MEDICAL CENTERPA370$621.6M-16.4%
UPMC ALTOONAPA337$526.8M-4.8%
COMMUNITY MEDICAL CENTERPA266$474.1M3.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.0M+210bp18mo
Cost to Collect4.5%2.5%$960K+200bp12mo
Denial Rate Reduction12.0%6.5%$950K+198bp12mo
A/R Days Reduction5200.0%3800.0%$584K+122bp9mo
Clean Claim Rate88.0%96.0%$31K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.0M
Cost to Collect
$960K
Denial Rate Reduction
$950K
A/R Days Reduction
$584K
Clean Claim Rate
$31K
Total EBITDA Uplift$3.5M
Current EBITDA$-369K
+ RCM Uplift+$3.5M
Pro Forma EBITDA$3.2M
Current Margin-0.8%
Pro Forma Margin6.6%
WC Released (1x)$1.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-568K$32.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-568K$36.0M0.00x-100.0%
Bull Case9.0x11.0x$-512K$47.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-512K$51.6M0.00x-100.0%
Bear Case11.0x10.0x$-625K$15.4M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-625K$16.8M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 98 hospitals with 96-384 beds
  • Same-state prioritization (n=99)
  • Comp margins: P25=-17.9% / P50=-7.6% / P75=2.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.